Cellectis S.A. (CLLS)

Cellectis Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-35.35	-36.76	-108.44	-114.03	-125.11
Depreciation & Amortization	20.79	19.85	18.52	18.44	14.16
Stock-Based Compensation	4.74	3.17	5.23	6.04	11.49
Other Adjustments	11.31	-16.93	23.12	11.09	-4.42
Change in Receivables	5.84	52.6	2.25	-3.19	-13.09
Changes in Inventories	-	-	-	-	0.22
Changes in Accounts Payable	-2.8	2.06	-6.31	3.25	0.18
Changes in Unearned Revenue	-32.21	5.75	59.15	0.02	-0.25
Changes in Other Operating Activities	-5.8	-6.73	-9.88	-24.41	-16.09
Operating Cash Flow	-29.09	22.99	-24.75	-87.44	-104.56
Capital Expenditures	-2.43	-2.58	-1.07	-2.43	-18.54
Purchases of Intangible Assets	-2.36	-1.26	-	-0.01	-0.01
Purchases of Investments	-202.27	-162.77	-13.36	-	-
Proceeds from Sale of Investments	152.67	63.81	-	-	15
Other Investing Activities	0.16	-0	-1.07	-0.32	10.84
Investing Cash Flow	-68.6	-102.81	-15.51	-2.76	7.28
Long-Term Debt Issued	6.88	23.2	29.67	5.75	-
Long-Term Debt Repaid	-5.03	-5	-5.11	-1.34	-
Net Long-Term Debt Issued (Repaid)	1.85	18.2	24.56	4.41	-
Issuance of Common Stock	-0	82.82	67.94	-0.57	56.24
Net Common Stock Issued (Repurchased)	-0	82.82	67.94	-0.57	56.24
Other Financing Activities	-11.55	-11.91	-9.64	-2.69	-8.72
Financing Cash Flow	-9.7	89.11	82.87	1.15	47.53
Effect of Exchange Rate Changes on Cash and Cash Equivalents	0.53	-2.75	0.88	-3.36	-5.75
Net Cash Flow	-106.85	6.54	43.49	-92.42	-55.51
Free Cash Flow	-31.52	20.41	-25.82	-89.88	-123.11
FCF Margin	-38.18%	41.46%	-280.85%	-349.38%	-318.95%
Free Cash Flow Per Share	-0.34	0.23	-0.45	-1.97	-2.75
Levered Free Cash Flow	-55.95	-0.23	-16.08	-106.87	-134.54
Unlevered Free Cash Flow	-48.08	-41.22	-36.58	-94.72	-123.82

Updated Nov 7, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q